This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: University of Leeds. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Helen Philippou: Innovator in Anticoagulant Research
Introduction
Helen Philippou is a distinguished inventor based in Leeds, GB. She has made significant contributions to the field of anticoagulant research, particularly through her innovative work on Factor XIIA inhibitors. Her research focuses on developing compounds that can effectively modulate Factor XII, which plays a crucial role in the blood coagulation process.
Latest Patents
Helen Philippou holds 1 patent related to her groundbreaking work. The patent pertains to Factor XIIA inhibitors, which are compounds designed to inhibit Factor XIIa. This invention not only includes the compounds themselves but also outlines methods of treatment and processes for producing these compounds. The potential applications of her work are significant, as these inhibitors may serve as effective anticoagulants.
Career Highlights
Helen is affiliated with the University of Leeds, where she conducts her research and collaborates with other experts in the field. Her work has garnered attention for its potential to improve treatment options for patients at risk of thrombotic events.
Collaborations
Helen has worked alongside notable colleagues, including Richard James Foster and Colin Fishwick. Their collaborative efforts have contributed to advancing research in anticoagulant therapies.
Conclusion
Helen Philippou's innovative research on Factor XIIA inhibitors represents a significant advancement in the field of anticoagulant therapy. Her contributions have the potential to enhance treatment options for patients, showcasing the importance of continued research and innovation in medicine.